once monthly glp 1 GLP-1 receptor agonist #pharmacy #medicine #weightlosssupport New Biweekly GLP-1 Shot Lowers
Description
SUMMARYIncretin therapy is based on the antidiabetic actions of the incretin hormone GLP-1
Compared with SGLT2i alone, combination therapy was significantly associated with 42% lower risk of ischemic stroke, 37% lower risk of MI, 46% lower risk of 3-point MACE, and 45% lower risk of 5-point MACE among people with T2D and ASCVD
Read more about why some cases arent so obvious.
Google GLP
Dementia risk was comparable between GLP1-RA versus SGLT2i in both intention-to-treat (HR 0.98, 95% CI 0.871.11
Strong market demand within wellness sectors
